{'output': [['Accelerate Diagnostics', 'ORG', 'Announce', 'Conformity to European In Vitro Diagnostic Directive 98/79/EC', 'ECON_INDICATOR'], ['Accelerate Diagnostics', 'ORG', 'Announce', 'CE mark of its latest assay', 'PRODUCT'], ['Accelerate Diagnostics', 'ORG', 'Participates_In', 'Study', 'EVENT'], ['Study', 'EVENT', 'Impact', 'Results for the severe pneumonia assay', 'ECON_INDICATOR'], ['Accelerate Diagnostics', 'ORG', 'Operate_In', 'Healthcare sector', 'SECTOR'], ['Accelerate Diagnostics', 'ORG', 'Raise', 'Preliminary revenue for the fourth quarter of 2017', 'ECON_INDICATOR'], ['Accelerate Diagnostics', 'ORG', 'Raise', 'Preliminary revenue for the full year of 2017', 'ECON_INDICATOR'], ['Accelerate Diagnostics', 'ORG', 'Control', 'Instruments under agreement', 'FIN_INSTRUMENT'], ['Accelerate Diagnostics', 'ORG', 'File', 'Financial results for the full year and quarter ending December 31, 2017', 'ECON_INDICATOR'], ['Accelerate Diagnostics', 'ORG', 'Produce', 'Accelerate Pheno™ system', 'PRODUCT'], ['Accelerate Diagnostics', 'ORG', 'Produce', 'Accelerate PhenoTest™ BC kit', 'PRODUCT'], ['Accelerate Diagnostics', 'ORG', 'Relate_To', 'Antimicrobial susceptibility testing', 'CONCEPT'], ['Accelerate Diagnostics', 'ORG', 'Relate_To', 'Antibiotic resistance', 'CONCEPT'], ['Accelerate Diagnostics', 'ORG', 'Relate_To', 'Healthcare-associated infections', 'CONCEPT'], ['Accelerate Diagnostics', 'ORG', 'Has', 'Diamond shaped logos and marks', 'PRODUCT']]}